Principles of Pediatric Anesthesia and Critical Care

May 6-8, 2022
Boston, MA

1st Virtual Conference
Live Streaming • April 30 - May 2, 2021

Keynote Speaker


Evan D. Kharasch, MD, PhD
Keynote Address: Anesthesia Pharmacogenetics

Dr. Kharasch is Merel H. Harmel Professor and Vice Chair for Innovation in the Department of Anesthesiology at Duke University, and also the Director of Academic Entrepreneurship in Duke University School of Medicine. Before joining Duke in 2018, Dr. Kharasch was at Washington University in St. Louis where he was the Russell D. and Mary B. Shelden Professor of Anesthesiology. He also created and was the founding Director of The Center for Clinical Pharmacology, a joint endeavor between the St. Louis College of Pharmacy and Washington University in St. Louis, and was the founding Director of the Division of Clinical and Translational Research in Anesthesiology. He also served as the Vice Chancellor for Research at Washington University in St. Louis. Prior to that, he was Professor of Anesthesiology, Vice-Chair for Research, and Assistant Dean for Clinical Research in the School of Medicine, at the University of Washington. He is the Editor-in-Chief of Anesthesiology, the leading journal in the specialty.

Dr. Kharasch leads an active research program in basic, translational and clinical pharmacology, and is a practicing anesthesiologist. His research broadly addresses anesthetic and analgesic drugs and addiction therapies, directed towards optimizing drug disposition, drug safety, clinical effectiveness and patient satisfaction. Specific interests include drug metabolism and transport (hepatic, renal, intestinal, and the blood-brain barrier), pharmacokinetics, pharmacodynamics, pharmacogenetics, toxicity, drug interactions, and variability in patient response, as well as perioperative pain and analgesia. His research also focuses on the development and application of novel noninvasive biomarkers and nanotechnology-based molecular diagnostics. He is the author of more than 280 research and scholarly manuscripts, as well as numerous book chapters, and is the editor of two major textbooks on anesthetic pharmacology.  

Guest Speakers


T. Anthony Anderson, MD, PhD

Dr. Anderson is an Associate Professor of Anesthesia in the Stanford University School of Medicine Department of Anesthesiology, Perioperative and Pain Medicine. He received his Ph.D. from the Massachusetts Institute of Technology, his M.D. from the University of Michigan, Ann Arbor, completed anesthesiology residency at the University of California, San Francisco, and a fellowship in pediatric anesthesia at Boston Children’s Hospital.
Dr. Anderson’s current research foci are on 1) pediatric perioperative outcomes to improve patient analgesia and safety, and 2) the use of novel treatment strategies for improving acute pain and reducing complications associated with pain and its management.  

Adrian T. Bosenberg, MBChB, FFA(SA)

Dr. Adrian Bosenberg is a Professor of Anesthesiology at the University of Washington.  He is a pediatric anesthesiologist and the former Director of Regional Anesthesia at Seattle Children’s Hospital.  His research interests include regional anesthesia in neonates and infants, anesthetic challenges in the developing world, influence of anesthesia on syndromes, inherited metabolic disorders and congenital anomalies, and difficult intubation techniques.


Thomas Caruso, MD, MEd

Dr. Thomas Caruso is a Clinical Associate Professor of Pediatric Anesthesiology. He specializes in the treatment of pediatric anesthesiology. Dr. Caruso has a special interest in regional anesthesia, quality and safety, medical education, and immersive technologies used for childhood pain and anxiety reduction.    

Christopher W. Connor, MD, PhD

Dr. Connor is Assistant Professor of Anesthesiology at Brigham and Women's Hospital, Harvard Medical School and adjunct Research Associate Professor of the Department of Physiology & Biophysics and the Department of Biomedical Engineering at Boston University. His research interests are on machine learning and anesthesia control systems. His NIH funding deals with using these techniques to infer the mechanisms of action of volatile agents on consciousness in the nematode C.elegans: a creature with only 302 neurons that is nevertheless anesthetizable and whose entire nervous system can be imaged non-invasively.

Dr. Connor recently published a review article in the journal Anesthesiology entitled “Machine Learning and Artificial Intelligence in Anesthesiology” and he will be speaking on this rapidly-evolving topic.

David Faraoni, MD, PhD, FAHA

From October 2014 - June 2016, Dr. Faraoni was a Visiting Assistant Professor of Anaesthesia at Harvard Medical School and Research Associate in the Department of Perioperative and Pain Medicine at Boston Children’s Hospital. He later joined the Hospital for Sick Children in July 2016 as a cardiac anesthesia fellow. Since July 2017, he has been a staff cardiac anesthesiologist at the Hospital for Sick Children and Associate Professor of Anesthesia at University of Toronto. He is a member of the board of director and the scientific committee of the Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis (NATA). He is an Associate Editor for Anesthesiology, Anesthesia & Analgesia, and Pediatric Anesthesia, as well as a member of the editorial board of the Journal of Cardiothoracic and Vascular Anesthesia.

Dr. Faraoni is also Associate Scientist in the Department of Translational Medicine at the Sick Kids Research Institute. His research program is focused on better understanding the coagulopathy in neonates and children with congenital heart disease and develop multimodal and multidisciplinary strategies to improve bleeding management and rationalize the use of blood products in this high risk population. He’s also interested in risk stratification for children with congenital heart disease undergoing non-cardiac surgery.

Frances E. Jensen, MD, FACP

Dr. Jensen is Professor and Chair of the Department of Neurology at the Perelman School of Medicine, University of Pennsylvania, and Co-Director of the Penn Medicine Translational Neuroscience Center. She is also the author of “The Teenage Brain: A Neuroscientist’s Survival Guide to Raising Adolescents and Young Adults” which has been published in over 25 languages worldwide. She was formerly Professor of Neurology, Harvard Medical School, Director of Translational Neuroscience and senior neurologist at Boston Children’s Hospital and Brigham and Women’s Hospital.
Dr. Jensen has researched brain development from the neonatal period through adulthood. Dr. Jensen’s research focuses on mechanisms of epilepsy and stroke, and the mechanistic interaction of epilepsy with other disorders such as autism and dementia, with specific emphasis on elucidating new therapies for clinical trials development. She has authored over 150 manuscripts on subjects related to her research and has been continuously funded by NIH since 1987 and received a NIH-NINDS Javits Award in 2020. In addition, Dr. Jensen is an advocate for awareness of the adolescent brain development, its unique strengths and vulnerabilities, as well as their impact on medical, social, and educational issues unique to teenagers and young adults. She lectures widely about the teen brain at science museums, TEDMED and high schools.

Catherine Sabatos-Peyton, PhD

Dr. Sabatos-Peyton is the Executive Director, Head of Immune Modulation, Exploratory Immuno-oncology, at Novartis Institutes for BioMedical Research.  During her Ph.D. at Harvard University, Catherine was part of the team that first described TIM-3, now understood as a critical immune and leukemic stem cell modulator in AML and MDS. Catherine went on to a postdoctoral fellowship at UCSF, followed by a fellowship at the University of Bristol in the UK. Catherine was Director of Immunology at CoStim Pharmaceuticals, developing therapeutic antibodies against checkpoint proteins for cancer treatment until its acquisition by Novartis in February 2014. Catherine has continued there, now as Head of Immune Modulation, bringing cancer therapeutic treatments to the clinic with a focus on preclinical research to establish novel therapies to overcome the suppressive tumor microenvironment.

Ellen Wang, MD

Dr. Ellen Wang is a Clinical Associate Professor of Pediatric Anesthesiology and Medical Director of Clinical Informatics for Perioperative Services at Lucile Packard Children’s Hospital Stanford. She is board-certified in Pediatric Anesthesiology and Clinical Informatics, with particular emphasis on EHR enhancement and optimization projects that support surgical, nursing, and pediatric and obstetric anesthesia workflows. She is also Chief of Operations of the Stanford Chariot Program, combining her interest in clinical care, process improvement, data analytics and research with virtual/augmented reality technologies to advance and evolve standards in patient care.